Literature DB >> 17223796

The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation.

Jing-He Huang1, Heng-Wen Yang, Shuwen Liu, Jing Li, Shibo Jiang, Ying-Hua Chen.   

Abstract

The HIV-1 gp41 (glycoprotein 41) core plays a critical role in fusion between the viral and target cell membranes. We previously identified a gp41 core-binding motif, HXXNPF, by screening the phage display peptide libraries. In the present study, we elucidated the mechanism of action of HXXNPF motif-containing molecules of different sizes, including the phage clone L7.8 (a selected positive phage clone), L7.8-g3p* (a 10-kDa fragment of the gene 3 protein) and JCH-4 (a peptide containing 13 residues of L7.8-g3p*), regarding their respective binding abilities to the six-helix bundle and inhibition on syncytium formation at different temperatures. We found that all of the HXXNPF motif-containing molecules could bind to the gp41 core, and that their binding sites may be located in the N-helix domain. L7.8-g3p* and JCH-4 effectively inhibited HIV-1 Env (envelope glycoprotein)-mediated syncytium formation at 37 degrees C, while the phage clone L7.8 showed no inhibition under the same conditions. However, at suboptimal temperature (31.5 degrees C), all of these HXXNPF motif-containing molecules were capable of inhibiting syncytium formation. These results suggest that these HXXNPF motif-containing molecules mainly bind to the gp41 core and stop the fusion process mediated by the fusion-active core, resulting in inhibition of HIV-1 fusion and entry. The HXXNPF motif-containing molecules may be used as probes for studying the role of the HIV-1 gp41 core in the late stage of the membrane-fusion process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223796      PMCID: PMC1876390          DOI: 10.1042/BJ20061275

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  The mechanism of inhibition of HIV-1 env-mediated cell-cell fusion by recombinant cores of gp41 ectodomain.

Authors:  Ruben M Markosyan; Xiuwen Ma; Min Lu; Fredric S Cohen; Grigory B Melikyan
Journal:  Virology       Date:  2002-10-10       Impact factor: 3.616

2.  Evolutionary stabilization of the gene-3-protein of phage fd reveals the principles that govern the thermodynamic stability of two-domain proteins.

Authors:  Andreas Martin; Franz X Schmid
Journal:  J Mol Biol       Date:  2003-05-09       Impact factor: 5.469

3.  HIV-1 inhibition by a peptide.

Authors:  S Jiang; K Lin; N Strick; A R Neurath
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

4.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

5.  Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.

Authors:  W Shu; J Liu; H Ji; L Radigen; S Jiang; M Lu
Journal:  Biochemistry       Date:  2000-02-22       Impact factor: 3.162

6.  N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.

Authors:  Shibo Jiang; Hong Lu; Shuwen Liu; Qian Zhao; Yuxian He; Asim K Debnath
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.

Authors:  Hana Golding; Marina Zaitseva; Eve de Rosny; Lisa R King; Jody Manischewitz; Igor Sidorov; Miroslaw K Gorny; Susan Zolla-Pazner; Dimiter S Dimitrov; Carol D Weiss
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Authors:  C Wild; T Oas; C McDanal; D Bolognesi; T Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation.

Authors:  Ruben M Markosyan; Fredric S Cohen; Grigory B Melikyan
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

10.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  7 in total

1.  Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides.

Authors:  Xi Chen; Lu Lu; Zhi Qi; Hong Lu; Ji Wang; Xiaoxia Yu; Yinghua Chen; Shibo Jiang
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.

Authors:  Yun Zhu; Lu Lu; Liling Xu; Hengwen Yang; Shibo Jiang; Ying-Hua Chen
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion core.

Authors:  Lu Lu; Yun Zhu; Jinghe Huang; Xi Chen; Hengwen Yang; Shibo Jiang; Ying-Hua Chen
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

4.  Interaction of HIV-1 gp41 core with NPF motif in Epsin: implication in endocytosis of HIV.

Authors:  Jing-He Huang; Zhi Qi; Fan Wu; Leszek Kotula; Shibo Jiang; Ying-Hua Chen
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

5.  The potent human immunodeficiency virus type 1 (HIV-1) entry inhibitor HR212 blocks formation of the envelope glycoprotein gp41 six-helix bundle.

Authors:  Wenjie Ouyang; Tai An; Deyin Guo; Shuwen Wu; Po Tien
Journal:  AIDS Res Hum Retroviruses       Date:  2013-01-11       Impact factor: 2.205

Review 6.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

7.  Novel screening systems for HIV-1 fusion mediated by two extra-virion heptad repeats of gp41.

Authors:  Hiroki Nishikawa; Eiichi Kodama; Ayako Sakakibara; Ayako Fukudome; Kazuki Izumi; Shinya Oishi; Nobutaka Fujii; Masao Matsuoka
Journal:  Antiviral Res       Date:  2008-06-12       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.